| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 156 |
| 1 | PREDNISONE | 155 |
| 2 | INFLIXIMAB | 153 |
| 3 | ACETAMINOPHEN | 152 |
| 4 | METHOTREXATE SODIUM | 143 |
| 5 | DIPHENHYDRAMINE HYDROCHLORIDE | 139 |
| 6 | METHOTREXATE | 131 |
| 7 | INFLIXIMAB-DYYB | 115 |
| 8 | ACETAMINOPHEN 500MG | 114 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 114 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 115 | 0.0334 |
| 1 | LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE | 1 | 0.0152 |
| 2 | LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE | 1 | 0.0152 |
| 3 | APADAMTASE ALFA | 1 | 0.0127 |
| 4 | CASIMERSEN | 8 | 0.0081 |
| 5 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 13 | 0.0068 |
| 6 | GARADACIMAB | 4 | 0.0052 |
| 7 | HYDROCORTISONE SODIUM SUCCINATE | 17 | 0.0043 |
| 8 | IBALIZUMAB | 2 | 0.0037 |
| 9 | HEMIN | 2 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 283 |
| 1 | Corticosteroid [EPC] | 272 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 206 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 131 |
| 4 | Integrin Receptor Antagonist [EPC] | 120 |
| 5 | Interleukin-23 Antagonist [EPC] | 93 |
| 6 | Vitamin C [EPC] | 84 |
| 7 | Provitamin D2 Compound [EPC] | 79 |
| 8 | Osmotic Laxative [EPC] | 76 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 70 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 11 | 0.0053 |
| 2 | Human alpha-1 Proteinase Inhibitor [EPC] | 19 | 0.0045 |
| 3 | CD4-directed Blocking Antibody [EPC] | 2 | 0.0037 |
| 4 | Human Immunoglobulin G [EPC] | 63 | 0.0030 |
| 5 | Plasma Kallikrein Inhibitor [EPC] | 7 | 0.0029 |
| 6 | CD3-directed Antibody [EPC] | 2 | 0.0028 |
| 7 | Provitamin D2 Compound [EPC] | 79 | 0.0027 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 31 | 0.0023 |
| 9 | Interleukin-17A Antagonist [EPC] | 66 | 0.0018 |